Our revenue-generating Prostate Core Mitomic Test is the highest performing prostate cancer diagnostic on the market. We are continuing to leverage our proprietary insights into the role of mtDNA as we develop an extensive portfolio of blood-based tests addressing numerous cancers, and Endometriosis.